3 Reasons Investors Love DexCom (DXCM)

Over the last six months, DexCom’s shares have sunk to $62.07, producing a disappointing 6.4% loss - a stark contrast to the S&P 500’s 5.1% gain. This may have investors wondering how to approach the situation.